Zusammenfassung
Die ersten Beobachtungen über eine temporäre Ovulationshemmung durch Hormone gehen bis auf Haberlandt[153] zurück, der schon 1921 zeigen konnte, daß die Transplantation von Ovarien schwangerer Versuchstiere auf geschlechtsreife Tiere gleicher Species zu einer zeitlich begrenzten Sterilität der Tiere mit den transplantierten Eierstöcken führt. Diese Wirkung wurde dem hohen Gehalt der transplantierten Ovarien an Corpus luteum-Hormon zugeschrieben.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Adlercreutz, H.: Cholestatic jaundice caused by contraceptive steroids and its relation to intrahepatic cholestatic jaundice of pregnancy. In: C. Cassano (ed.), Research on steroids, vol. II, p. 521. Rom: Il pensiero Scientifico 1966.
Amreich, J.: Antikonzipientia und die durch sie verursachten Schädigungen. Wien. med. Wsehr. 112,9 (1962).
Anderton, E.: Clinical trials of oral progestogens. Proc. 7th Conf. Int. Planned Parenthood Fed., Singapore 1963. Excerpta med. (Amst.), Int. Congr. Ser. 72,389 (1964).
Andolsek, L.: Influence of estrogen-progestin combinations on menstrual cycle. In: C. Cassano (ed.), Research on steroids, vol. II, p. 447. Rom: II Pensiero Scientifico 1966.
Andreoli, C.: Human endometrial picture after sequential and combination regimen. In: C. Cassano (ed.), Research on steroids, vol. II, p. 469. Rom: II Pensiero Scientifico 1966.
Andreoli, C., E. Morano, and P. Yischi: Endometrial morphology under the optical and electron microscope after prolonged treatment with some estroprogestational combinations. Excerpta med. (Amst.), Int. Congr. Ser. III, 352 (1966).
Andrews, W. C., and M. C. Andrews : The use of progestins for oral contraception. Sth. med. J. (Bgham, Ala.) 55,454 (1962).
Andrews, W. C., and M. C. Andrews Reduction of side effects from ovulation suppression by the use of newer progestin combinations. 19th Ann. Meeting Amer. Soc. Study Steril., p. 75. New York 1963.
Andrews, W. C., and M. C. Andrews Patient acceptance of oral contraceptives. Metabolism 14,446 (1965).
Apostolakis, M.: The effects of HCG and ACTH on the urinary excretion of testosterone and epitestosterone in male patients with various endocrine disorders. Proceed. The Pord Foundation Int. Conf. on the physiology of human reproduction, Venice, p. 17 (1966).
Arnold, M., St. Cloeren, M. Mall, E. More, R. H. H.Richter, Fr. Roth, H. Stamm u. H. Wyss: Vorläufige Resultate vergleichender Versuche mit oralen Kontrazeptiva, 2. Teil. Verhandl. Jahresversammlung der Schweiz. Gesellschaft f. Gynäk., Juni 1966,Lugano.
Ayre, J. E.: Influence of Enovid upon carcinoma in situ and precancerous cervical lesions. Proc. IVth World Congr. Int. Ped. Gynec. Obstet. 1964.
Baines, G. F.: Jaundice in a patient taking norethisterone compound tablets. Lancet 19651,No 7376,108.
Bakker, C. B., and C. R. Dightman: Psychological factors in fertility control. Fertil. and Steril. 15,559 (1964).
Bayot, Dr.: Study of liver function during hormonal antiovulatory treatment. In: C. Cassano (ed.), Research on steroids, vol. II, p. 513. Rom: II Pensiero Scientifica 1966.
Becker, F. T.: Porphyria cutanea tarda induced by estrogens. Arch. derm. 92,252 (1965).
Becker, W.: Unerbetene Bander. Med. Klin. 59,1402 (1964).
Behrmann, S. J.: Comparative findings in control of ovulation with various steroids. Excerpta med. (Amst.) Int. Congr. ser. 111,198 (1966).
Bell, E. T., A. L.Herbst, M. Krishnamurti, and J. A. Loraine: Urinary gonadotrophs excretion during and following long-term therapy by oral progestogens. Excerpta med. (Amst.) Int. Congr. Ser. 111,197 (1966).
Berkoth, E.: Zur Zyklusanalyse aus dem Zervikalsekret. Z. Geburtsh. Gynäk. 147,76 (1956).
Besch, P. K., R. D.Barry, N. Vorys, V. Stevens, and J. C. Ullery: A review of some aspects of the metabolism of progestational agents. Metabolism 14,432 (1965).
Besch, P. K., N. Vorys, J. C.Ullery, V. Stevens, and R. D. Barry: Some systemic effects of a progestational agent. Metabolism 14,387 (1965).
Bialy, G., and G. Pincus : The pharmacology of progesterone. Med. Ann. D.C. 81,136 (1962).
Bickenbach, W., u. E. Paulikovics: Hemmung der Follikelreifung durch Progesteron bei der Frau. Zbl. Gynäk. 68,153 (1944).
Binks, R., P. Cambourn, and R. A. Pap worth: Preliminary report of a clinical trial of oral norethynodrel for fertility control. Med. J. Aust. 1962 I, 716.
Board, J. A., and D. S. Borland: Sequential oral contraception using DMAP. Fertil. and Steril. 17,234 (1966).
Bockner, V.: The contraceptive pill: A clinical evaluation of its long-term use. Med. J. Aust. 1963 I, 809.
Böhnel, J., u. A. Stacher: Erhöhte Thrombosebereitschaft durch Ovulationshemmer? Med. Klin. 60,1951 (1965).
Borglin, N.: Inhibitory effect of Lynestrenol and Lyndiol on human ovarian function. Int. J. Fertil. 9,17 (1964).
Borglin, N. E.: Oral contraceptives and liver damage. Brit. med. J. 19651,1289.
Borushek, S., M. R. Abell L.Smith, and J. J. Gold: Effects of Provest on the endometrium. Int. J. Fertil. 8,605 (1963).
Bottermann, P., K. Kopetz, P. Dieterle, P. C.Scriba, W. Hochheuser, K. Schleypen, K. Horn, M. Dambacher u. K. Schwarz: Klinische Untersuchungen über die Glukosetoleranz sowie Bestimmungen von Insulin, Trijodthyronin-Bindung und der 11-Hydroxycorticosteroide im Serum unter einer Gestagen-Oestrogen-Therapie. Kongreßbericht 12. Symposion der Deutschen Gesellschaft für Endokrinologie Wiesbaden, 1966.
Bowman, R.: Some clinical experience in the oral control of conception. Med. J. Aust. 19621,715.
Braitenberg, H., u. L. Veltkay: Zur therapeutischen Verwendbarkeit der hormonellen Ovulationsblockade. Wien. med. Wschr. 113,716 (1963).
Brehm, H.: Circulation, blood coagulation and clinical observations during hormonal suppression. Int. J. Fertil. 9,45 (1964).
Brehm, H., Über moderne Konzeptionsverhütung. Praxis 54,1154 (1965).
Breuer, H.: Studies on the metabolism of 17a-ethinyl-19-nortestosterone. Int. J. Fertil. 9,181 (1964).
Brown, J. B., and H. A. F. Blair: Urinary oestrogen metabolites of 19-norethisterone and its esters. Proc. roy. Soc. Med. 58,433 (1960).
Brown, J. B., K. Fotherby, and J. A. Loraine: The effect of 17a-ethinyl-19-nortesterone (norethisterone) on the urinary excretion of oestrogens, pregnandiol and gonadotrophins during the menstrual cycle. Proc. roy. Soc. Med. 58,341 (1960).
Buchholz, R.: Untersuchungen über die Beeinflussung der Gonadotropinausscheidung beim Menschen durch Keimdrüsenhormone. Geburtsh. u. Frauenheilk. 19,851 (1959).
Buchholz, R., L. Nocke u. W. Nocke: Untersuchungen über den Wirkungsmechanismus von Äthinylnortestosteron bei der Unterdrückung der Ovulation. Geburtsh. u. Frauenheilk. 22,923 (1962).
Buchholz, R., L. Nocke u. W. Nocke The influence of gestagens on the urinary excretion of pituitary gonadotropins, estrogens and pregnanediol in women in the postmenopause and during the menstrual cycle. Int. J. Fertil. 9,231 (1964).
Buchler, D., and J.C. Warren: Effects of estrogen on glucose tolerance. Amer. J. Obstet. Gynec. 95,479 (1966).
Büngeler, W., u. W. Dontenwill: Fragekastenantwort (Hormone und Krebs). Münch. med. Wschr. 102,985 (1960).
Büngeler, W., u. W. Dontenwill Hormonell ausgelöste geschwulstartige Hyperplasien, hyperplasiogene Ge schwülste und ihre Verhaltensweisen. Dtsch. med. Wschr. 84,1885 (1959).
Butler, J. K. : A review of mortality statistics relating to thromboembolic disease in oral contraceptive users and in non-users. In: O. Cassano (ed.), Research on steroids, vol. II, p. 509. Rom: II Pensiero Scientifico 1966.
Carlström, H., S. Höglund, and P. Reizenstein: Oral contraceptives and liver damage, correspondence. Brit. med. J. 1965 I, No 5440,993.
Chang, M. C., and R. Yanagimachi: Effect of estrogens and other compounds as oral antifertility agents on the development of rabbit ova and hamster embryos. Fertil. and Steril. 16,281 (1965).
Charles, D.: Iatrogenic endometrial pattern. In: C. Cassano (ed.), Research on steroids, vol. II, p. 477. Rom: H Pensiero Scientifico 1966.
Cherniok, B. A.: Side effects of cyclic therapy with norethindrone and mestranol. Fertil. and Steril. 16,445 (1965).
Chinnatamby, S.: I. Clinical trial of oral contraceptives Enovid and Conovid. II. Effect of oral contraceptive (Conovid E) on lactation. Proc. 7th Conf. Int. Planned Parenthood Fed., Singapore 1963. Excerpta med. (Amst.), Int. Congr. Ser. 72,319 (1964).
Chinnatamby, S., Inhibition of ovulation. Excerpta med. (Amst.), Int. Congr. Ser. 111,196 (1966).
Chung Ching San: Clinical trials on oral contraceptives in Singapore Family Planning Association. Proc. 7th Conf. Int. Planned Parenthood Fed., Singapore 1963. Excerpta med. (Amst.), Int. Congr. Ser. 72,382 (1964).
Clauberg, C.: Ovarium, Hypophyse und Schwangerschaft in ihrer Beziehung zur Frauenheilkunde. In: Handbuch der Gynäkologie, hrsg. von Yeith u. J. W. Stöckel, 3. Aufl., 9. Bd., S. 368. München: J. F. Bergmann 1936.
Clyman, M. C.: Electron-microscopic changes produced in the human endometrium by norethindrone acetate with ethinyl estradiol. Fertil. and Steril. 14,352 (1963).
Cobb, J. C., S. Farhat, N. A.Shah, S. J. Ameen, and P. Harper: Oral contraceptive program synchronized with moon phase. Fertil. and Steril. 17,559 (1966).
Cohen, M. R., and M. Perez-Pelaez: The effect of norethindrone acetate-ethinyl estradiol clomiphene citrate and Dydrogesterone on Spinnbarkeit. Fertil. and Steril. 16,141 (1965).
Cook, H.H., C. J. Gamble, and A. P. Satterthwaite: Oral contraception by norethinodrel. Amer. J. Obstet. Gynec. 82,437 (1961).
Copeman, P. W. M., D. J. Cripps, and R. Summerly: Cutaneous hepatic prophyria and oestrogens. Brit. med. J. 1966 I, 461.
Coutinho, E. M., J. C. De Souzy, and A. I. Csapo: Reversible sterility induced by medroxyprogesterone injections. Fertil. and Steril. 17,261 (1966).
Council on Drugs: New drags and developments in therapeutics Norethinodrel with mestranol (envoid). J. Amer. med. Ass. 183,949 (1963).
Cross, J. W.: New synthetic steroid progestins. Fertil. and Steril. 10,361 (1959).
Cullberg, G., R. Lundström, and U. Stenram: Brit. med. J. 1965 I, No 5436,695.
Dacic, Z.: Serum-Enzymuntersuehungen zur Frage der Leberschädigung durch orale Ovulationshemmer. Med. Welt 2,108 (1966).
Datta, H., R. Nath, and R. R. Chaudhury: Oral contraceptives and liver damage. Brit. med. J. 1965 II, 476.
Dean, G.: Oral contraceptives in porphyria variegata. S.Afr. med. J. 89,279 (1965).
Demol, R., and J. Ferin: The urinary gonadotropin content during treatment with Lynestrenol. Int. J. Fertil. 9,197 (1964).
Desaulles, P. A., u. C. Krähenbühl: Moderne Entwicklung auf dem Gebiet der Gestagentherapie. 6. Sympos. dtsch. Ges. Endokr. 1959,S. 1. Berlin-Göttingen- Heidelberg: Springer 1960.
Desaulles, P. A., u. C. Krähenbühl Comparaison du spectre d’activité de certains gestagènes de synthèse. Acta endocr. (Kbh.) 40,217 (1962).
Diczfalusy, E.: Probable mode of action of oral contraceptives. Brit. med. J. 1965 II, 1394.
Diczfalusy, E. Probable mode of action of oral contraceptives. In: C. Cassano (ed.), Research on steroids, vol. II, p. 389. Rom : II Pensiero Scientifico 1966.
Diczfalusy, E., E. Johannisson, K.-G. Tillinger, and G. Bettendore : Studies on the effect of testosterone on the ovarian response to exogenous human hypophysial gonadotrophs (HHG) in amenorrhoeie women. J. Int. Fed. Gynaec. Obstet. 1,145 (1963).
Diddle, A. W., G. F.Watts, W. H. Gardner, and P. J. Williamson: Oral contraceptive medication: A prolonged experience. Amer. J. Obstet. Gynec. 95,489 (1966).
Dietel, H.: Konzeptionsverhütung. Hamburger Ärztebl. 16,112 (1962).
Dingle, J. T.: Preliminary report on Provest study. Int. J. Fertil. 8,711 (1963).
Dockerty, M. B., R.A. Smith, and R. E. Symmonds: Pseudomalignant endometrial changes induced by administration of new synthetic progestins. Proc. Mayo Clin. 34,321 (1959).
Dodek, O. I., E. J. Segre, and E. L. Klaiber: Effects of enovid on Cortisol metabolism. Amer. J. Obstet. Gynee. 93,173 (1965).
Doering, P., u. E. Schmele: Ergebnisse des J131-Trijodthyromntestes mit einem Ionenaustauscherharz. Strahlenforsch, u. Strahlenbeh. 4,272 (1963).
Doran, T. A., J. L.Harkins, A. G. Gornall, and D. W. Thompson: Clinical and laboratory assessment of a new progestational agent. Canad. med. Ass. J. 91,900 (1964).
Döring, G. K.: Kann der Wechsel zwischen verschiedenen Ovulationshemmern nach teilige Folgen haben ? Dtsch. med. Wschr. 17,785 (1965).
Döring, G. K. Darf eine stillende Mutter Ovulationshemmer einnehmen oder sind Schädigungen beim Säugling zu befürchten? Dtsch. med. Wschr. 90,2176 (1965).
Döring, G. K. Empfängnisverhütung. Stuttgart: Georg Thieme 1966.
Döring, G. K. Sind nach längerer kontrazeptiver Therapie mit Ovulationshemmern eine erhöhte Konzeptionschance und eine Häufung von Mehrlingsgeburten zu beobachten? Dtsch. med. Wschr. 91,1134 (1966).
Döring, G. K., L. Akhundzaden u. B. Herzing: Über den Bremseffekt von Methyl-Nortestosteron auf die Ovarialfunktion weißer Ratten. Arch. Gynäk. 192,129 (1959).
Dohrmann, R. E., u. G. Giffels: Das Verhalten der Glutamat-Pyruvat-Transaminase, Aldose, ß- Glukuronidase und des Eiweißspektrums im Serum unter der Einwirkung eines Ovulationshemmers. Med. Klin. 60,1844 (1965).
Dominguez, H., F. Simowitz, and R. B. Greenblatt: Clinical evaluation of a new oral progestinchlormadinone. Amer. J. Obstet. Gynec. 84,1478 (1962).
Donayre, J., and G. Pinous: Effects of enovid on blood clotting factors. Metabolism 14,411 (1965).
Dontenwill, W. : Bedeutung der Hormone für die Geschwulstentstehung. Zbl. Gynäk. 83,1704 (1961).
Dontenwill, W. Kolposkopische, zoologische und histologische Portiobefunde unter ovulationshemmender Medikation. Münch, med. Wschr. 107,491 (1965).
Drill, V. A.: Steroids inhibiting ovulation. Jap. J. Pharmacol. 11,88 (1962).
Drill, V. A. Contraceptive effect of oral progestins. Properties of SC 11800,a new oral ovula tion inhibitor. Proc. 7th Conf. Int. Planned Parenthood Fed., Singapore 1963. Excerpta med. (Amst.), Int. Congr. Ser. 72,427 (1964).
Drill, V. A. Endocrine properties and long-term safety of oral contraceptives. Metabolism 14,295 (1965).
Dijkes, M. N. G., H. Kopera, and G. L. Ijzermann: Clinical experience with cyclical administration of lynestrenol in combination with an estrogen for fertility control. Proc. 7th Conf. Int. Planned Parenthood Fed., Singapore 1963. Excerpta med. (Amst.), Int. Congr. Ser. 72,336 (1964).
Eckstein, P., J. A. H.Waterhouse, G. M.Bond, W. G.Mills, D. M. Sandilands, and D. M. Shotton: The Birmingham oral contraceptive trial. Brit. med. J. 1961 II, 1172.
Egeberg, O., and P. A. Owren: Oral contraception and blood coagulability. Brit. med. J. 1968 I, 220.
Eger, W.: The necrotropic liver-protective substances. In: The liver, vol. II, p. 553. New York: Academic Press 1964.
Eichner, E.: The clinical uses of Provest. Int. J. Fertil. 8,673 (1963).
Eichner, E. Medroxyprogesterone acetate. Its use in family spacing. Ohio St. med. J. 59,684 (1963).
Eisalo, A., P. A. Järvinen, and T. Luukkatnen: Hepatic impairment during the intake of contraceptive pills: Clinical trial with postmenopausal women. Brit. med. J. 1964 II, 426.
Eisalo, A., P. A. Järvinen, and T. Luukkatnen, Liver-function tests during intake of contraceptive tablets in pre-menopausal women. Brit. med. J. 1965 I, No 5447,1416.
Ellington, E. F., A. N. Contopoulos, and M. T. Clegg: The influence of progesterone on pituitary gonadotrophic secretion. Proc. 7th Conf. Int. Planned Parenthood Fed. Singapore 1963. Excerpta med. (Amst.), Int. Congr. Ser. 72,487 (1964).
Elliott, J., and J. Hendry: Cholestatic jaundice complicating pregnancy: recurrence after norethynodrel with ethynylestradiol (Enovid). Canad. med. Ass. J. 92,344 (1965).
Epstein, J. A., H. S. Kuppermann, and A. Cutler: Comparative pharmacological and clinical activity of 19-Nortestosterone and 17-hydroxy-progesterone derivatives in man. Ann. N.Y. Acad. Sci. 71,560 (1958).
Erb, H., u. H.Keller: Klinische und experimentelle Erfahrungen mit hormonalen Ovulationshemmern. Gynaecologia (Basel) 158,1 (1964).
Erb, H., u. K.S.Ludwig: Corpus-luteum-Bildung während Einnahme eines hormonalen Antikonzeptivums. Gynaecologia (Basel) 159,309 (1965).
Ercoli, A.: Personal Research within the framework of a short history of the fertilityantifertility steroids. In: C. Cassano (ed.), Research on steroids, vol. II, p. 393. Rom: II Pensiero Scientifico 1966.
Esoda, E. C. J.: Chloasma from progestational oral contraceptives. Arch. Derm. 87,486 (1963).
Falconi, G.: A proposed new procedure for the evaluation of antiovulatory drugs in the rat. In: C. Cassano (ed.), Research on steroids, vol. II, p. 375. Rom: II Pensiero Scientifico 1966.
Faust, J. M., and E. T. Tyler: Ophthalmologic findings in patients using oral contra ception. Fertil. and Steril. 17,1 (1966).
FDA (Food and Drug Administration; USA): Report on Enovid. J. Amer. med. Ass. 185,774 (1963).
FDA Statement on oral contraceptives. F-D-C-Reports, August 15th, 1966.
Felton, H. T., E. W. Hoelscher, and D.P.Schwartz: Evaluation of use of an injectable progestinestrogen for contraception. Fertil. and Steril. 16,665 (1965).
Ferin, J., J. Charles, G. Rommelart, and A. Beuseelinck: Ovarian inhibition during lactation. Int. J. Fertil. 9,41 (1964).
Finkelstein, M., D. Serr, and J. Weideneeld : Evaluation of ovarian function in; women by the estimation of urinary pregnanetriol during treatment with 19-norsteroids. I: C. Cassano (ed.), Research on steroids, vol. II, p. 399. Rom: II Pensiero Scientifico 1966.
Firat, D., and L. Stutzman: Blood thrombocyte levels after administration of equine estrogens. Proc. Soc. exp. Biol. (N.Y.) 103,474 (1960).
Flowers jr. C. E.: New developments in ovulation control. In: E. Goldfarb, Advances in the tratment of menstrual dysfunction, p. 141. Philadelphia: Lea & Febiger 1964.
Fotherby, K., S. Kamyab, and P. Littleton: Metabolism of synthetic progestational compounds. J. Endocr. 8,33 (1965).
Fotherby, K., P. Littleton, S. Kamyab, and A. Klopper: Metabolism of synthetic progestational compounds in humans. Excerpta med. (Amst.), Int. Congr. Ser. 111,198 (1966).
Frank, R.: Use of oral compounds. Proc. 7th Conf. Int. Planned Parenthood Fed. Singapore 1963. Excerpta med. (Amst.), Int. Congr. Ser. 72,323 (1964).
Frank, R., and Chr. Tietze: Acceptance of an oral contraceptive program in a large metro politan area. Amer. J. Obstet. Gynec. 98,122 (1965).
Frerichs, H., S. Grote, E. Severidt u. W. Creutzfeldt: Änderungen der Glukose assimilation im Verlauf des Menstruationszyklus und während der Behandlung mit einem Ovulationshemmer (Äthinylnortestosteronacetat, Anovlar). Verh. 12. Symposion der Deutschen Gesellschaft für Endokrinologie und 2. Tag. Dtsch. Diabetes- Gesellschaft, Wiesbaden. Berlin-Göttingen-Heidelberg: Springer 1966.
Frick, H. C.: Progestational drugs in the management of endometrial cancer. Meta bolism 14,348 (1965).
Fuchs, F., S. Johnsen, and K. Alling Moeller: Studies on pituitary, adrenocortical and ovarian function during treatment with medroxyprogesterone acetate. Int. J. Fertil. 9,147 (1964).
Garcia, C. R., and G. Pincus : Clinical consideration of oral hormonal control of human fertility. Clin. Obstet. Gynec. 7,844 (1964).
Garcia, C. R., and G. Pincus, Ovulation inhibition by progestin-estrogen combination. Int. J. Fertil. 9,95(1964)
Garcia, C. R., and G. Pincus, and J. Rock: Effects of three 19-norsteroids on human ovulation and menstrua tion. Amer. J. Obstet. Gynec. 75,82 (1958).
Garcia, C. R., J. Rock, and G. Pincus : Observations on prolonged administration of Enovid. In: Proe. of a Sympos. on Enovid, Chicago, 25th November, 1958.
Gershberg, H., Z. Javier, and M. Hülse: Glucose tolerance in women receiving an ovulatory suppressant. Diabetes 18,378 (1964).
Geschickter, Ch. F., and C. G. Hajrtmann: Mammary response to prolonged estrogenic stimulation in the monkey. Cancer (Philad.) 12,767 (1959).
Gesenius, H.: Orale Empfängnisverhütung. Med. Klin. 58,897 (1963).
Gold, J. J., A. Scommegna, and S. Borushek: The clinical use of ovulation sup pressants. Med. Clin. N.Amer. 47,131 (1963).
Gold, J. J., L. Smith, A. Scommegna, and S. Borushek: The efficacy of Provest in inhibiting ovulation. Int. J. Fertil. 8,725 (1963).
Goldfarb, A. F.: Clinical experience with Provest. Int. J. Fertil. 8,635 (1963).
Goldfarb, A. F. Uterine utilisation of steroids. Its role in oral contraception. Metabolism 14,339(1965).
Goldzieher, J. W.: The use of newer progestins as oral contraceptives and in uterine carcinoma. New Phycn. 27,265 (1962).
Goldzieheb, J. W.: Newer drugs in oral contraception. Med. Clin. N. Amer. 48,529 (1964).
Goldzieher, J. W., C. Becebba, C. Gual, N. B. Livingston jr., M. Maqtjeo, L. E. Moses, and C. Tietze: New oral contraceptive. Sequential estrogen and progestin. Amer. J. Obstet. Gynec. 90,404 (1964).
Goldzieher, J. W. N. B. Livingston jr., J. Martinez Manatjtou, and L. E. Moses : The use of sequential estrogen and progestin to inhibit fertility. Proc. 7th Conf. Int. Planned Parenthood Fed., Singapore 1963. Excerpta med. (Amst.), Int. Congr. Ser. 72,325 (1964).
Goldzieher, J. W. J. Mabtinez-Manautou, N. B. Livingston jr., L. E. Moses, and E. Rice-Wbay: The use of sequential estrogen and progestin to inhibit fertility. West. J. Surg. 71,187 (1963).
Goldzieher, J. W. J. Mabtinez-Manautou, N. B. Livingston jr., L. E. Moses, and E. Rice-Wbay, Die Zweiphasenbehandlung mit einer ovulationshemmenden östrogen- Gestagen-Kombination. Fortsehr. Med. 82,739 (1964).
Goldzieher, J. W., L. E. Moses, and U. L. T. Ellis: Study of norethindrone on contraception. J. Amer. med. Ass. 180,359 (1962).
Goldzieher, J. W., and E. R. Rice-Wbay: Oral contraception. Ch. C. Thomas 1966.
M. Schulz-Contbebas, and A. Aranda-Rosell : Fertility following termination of contraception with norethindrone. Amer. J. Obstet. Gynec. 84,1474 (1962).
Gould, J.: Control of ovulation with Provest. Int. J. Fertil. 8,737 (1963).
Gbaffi, A., u. H. Gummel: Zur Frage der eancerogenen Wirkung der Steroiden Gesehlechtshormone. Dtsch. Gesundh.-Wes. 7,1250 (1952).
Gbeenblatt, R. B.: Antiovulatory drugs and indications for their use. Med. Clin. N.Amer. 45,973 (1961).
Gboff, D. N.: Suggestion for control of epilepsy. N.Y. St. J. Med. 62,3017 (1962).
Gbumbach, M. M., J. R. Duchabme, and R. E. Moloshok: On the fetal masculinizing action of certain oral progestins. J. clin. Endoer. 19,1369 (1959).
Guhb, O.: Kolpokopische, zytologisehe und histologische Portiobefunde unter ovulationshemmender Medikation. Münch, med. Wschr. 107,485 (1965).
Guhb, O., Kolposkopische, eytologisehe und histologische Portiobefunde bei ovulations hemmenden Medikamenten. Arch. Gynäk. 202,205 (1965).
Guhb, G.: Beitrag über die Wirkung von Ovulationshemmern auf das Plattenepithel der Portio uteri. Zbl. Gynäk. 25,815 (1966).
Guttmacheb, A. F.: Oral contraception. Postgrad. Med. 82,552 (1962).
Habeblandt, L.: Über hormonale Sterüisierung des weiblichen Tierkörpers. Münch. med. Wschr. 68. 1577 (1921).
Haefeli, H., St. Cloeben u. M. Mall: Ovulationshemmer und Emboliegefahr. Gynaecologia (Basel) 160,281 (1965).
de Haen, P.: Sequential medication for birth control. Med. Sei. 13,319 (1963).
Halbebstadt, E.: Gerinnungsveränderungen unter oralen Antieonzipientien. Beitr. zur Fertil. u. Steril., S. 102. Stuttgart: Ferdinand Enke 1964.
Hall, R. E.: Enovid and thrombophlebitis. Bull. Sloane Hosp. Worn. N.Y. 9,17 (1963).
Halleb, J.: Über die Einwirkung von 17a-Äthinyl-19-Nortestosteronönanthat auf Hypophysenzwisehenhirnsystem und Uteruswachstum virgineller Meerschweinchen. Acta endocr. (Kbh.) 35,Suppl. 51,456 (1960).
Halleb, J. Empfängnisverhütung durch synthetische Hormone. Landarzt 36,77 (1960).
Halleb, J. Der Wirkungsmechanismus der Nor-Gestagene. Klin. Wschr. 38,619 (1960).
Halleb, J. Vergleichende Prüfung der Wirkung neuer synthetischer Gestagene auf Hypophyse und Genitalorgane im „Milzovar-Planimetertest“. Verh. III. Weltkongr. Gynäk. Geburtsh., Bd. I, S. 75. Wien: Verlag d. Wien. med. Akad. ärztl. Fortb. 1961.
Halleb, J. Beeinflussung der Ovulation durch Gestagene. Geburth. u. Frauenheilk. 22,211 (1962).
Halleb, J. Reversibility of norethisterone-acetate induced inhibition of gonadotropic function in the “splenic ovarian graft planimetrie test”. Abstr. I. Int. Congr. Hormonal Steroids, Milano 1962. Excerpta med. (Amst.), Int. Congr. Ser. 51,153 (1962).
Halleb, J. Reversibility of gestagen-induced gonadotrophs inhibition in guinea-pigs. Proceed ings of the biological sessions at the IPPF Conference Singapore 1963. Excerpta med. (Amst.), Int. Congr. Ser. 72,455 (1964).
Halleb, J. Die medikamentöse Hemmung der Ovulation. Referat 4. Tagung der Bayerischen, österreichischen und Schweizer Gesellschaft für Geburtshilfe u. Gynäkologie, 4. 10. 1963,Luzern. Fortsehr. Geburtsh. Gynäk. 21,37 (1965).
Halleb, J. Klinische und tierexperimentelle Testierung neuer synthetischer Gestagene. Fort sehr. Med. 82,529 (1964).
Halleb, J. Referat: Homonale Kontrazeption in Deutschland; und Rundtischgespräch über hormonale Kontrazeption und deren Nebenerscheinungen. 13. Kongr. ärztl. Fortbildg., 22. 5. 1964,Berlin. Berl. Ärztebl. 11,190 (1964).
Haller, J.: Aussprache zu Vortrag von O. Guhr : Kolposkopische, cytologische und istho- logisehe Portiobefunde bei ovulationshemmenden Medikamenten. Arch, für Gynäk. 202,218 (1965).
Haller, J. Ovulationshemmung durch Hormone, Monographie, 2. verb. Aufl. Stuttgart: Georg Thieme 1968.
Haller, J. Thrombose und Hormonbehandlung. Dtsch. med. Wschr. 90,2124 (1966).
Haller, J. The influence of long-term treatment with oral contraceptives on thyroid, adrenal, and liver. Proceed. The Pord Found. Int. Conf. on the physiology of human reproduction, Venice, p. 34 (1966).
Haller, J. Indikationen zur Behandlung mit den sogenannten Ovulationshemmern. Dtsch. med. Wschr. 91,1653 (1966).
Haller, J. Mechanism of action of antifertility agents. In: C. Cassano (ed.), Research on steroids, vol. II, p. 379. Rom: II Pensiero Scientifico 1966.
Haller, J., u. H. Kirchhofe : Zur Frage der Kontrazeption. Teil II. Hormonale Kontrazeption. Internist (Berl.) 6,242 (1964).
Haller, J. A. König u. H. Poliwoda: Hormonausscheidung und Blutgerinnungsfaktoren unter oraler Gestagen-Östrogenbehandlung (Beurteilung des Thrombophlebitisrisikos). Geburtsh. u. Frauenheilk. 25,215 (1965).
Haller, J. R. Zichel u. H. U. Pixberg: Veränderungen des J-131-Trijodthyronintestes unter Hormonbehandlung und bei Störungen der Schwangerschaft. Geburtsh. u. Frauenheilk. 26,624 (1966).
Halter, G., G. Mestwerdt, C. Müller, K. Podleschka, W. Riffart u. H. Siebke : Umfrage über orale Antikonzeptions-Mittel. Münch, med. Wschr. 106,1113 (1964).
Harmsen, H., u. G. Fromm: Physiologische Möglichkeiten einer zeitweiligen Beschrän kung der Empfängnisfähigkeit. Med. Welt 1960,354.
Hass, T.: Experience with Provest in private practice. Int. J. Fertil. 8,743 (1963).
Hauser, G. A.: Praktische Erfahrungen mit Ovulationshemmern. Fortsehr. Geburtsh. Gynäk. 21,123 (1965).
Hauser, G. A. Contraceptive methods practiced among the population of central Switzerland. Proceed. The Ford Found. Int. Conf. on the physiology of human reproduction, Venice, p. 37 (1966).
Hauser, G. A., and M. Girotti: The menstrual cycle after oral contraception. Proceed. The Ford. Found. Int. Conf. on the physiology of human reproduction, Venice, p. 36 (1966).
Hauser, G. A., u. V. Schubiger: Nebenerscheinungen der ovulationshemmenden Präparate. Arch. Gynäk. 202,175 (1965).
Hauser, G. A., u. V. Schubiger Why do women discontinue the pill ? Proceed. The Ford Found. Int. Conf. on the physiology of human reproduction, Venice, p. 36 (1966).
Hecht-Lucari, G.: Über die gegenseitige Beeinflussung von Progesteron und Äthinyl- Nortesteron. Experimenteller Beitrag. 6. Sympos. dtsch. Ges. Endokrin., Kiel 1959,S. 53. Berlin-Göttingen-Heidelberg: Springer 1960.
Hecht-Lucari, G. Fertilitätshemmende und nichthemmende orale Gestagene. Beitrag zur Fertilität und Sterilität, S. 89. Stuttgart: Ferdinand Enke 1964.
Hecht-Lucari, G. Central and peripheral action of fertility-inhibiting progestogens. Int. J. Fertil. 9,205 (1964).
Hecht-Lucari, G. H. G. Kraft, and H. Kieser: Estrogenic, antiestrogenic and antifertility activity of Chlormadinone acetate and other steroidal and non-steroidal compounds. In: C. Cassano (ed.), Research on steroids, vol. II, p. 357. Rom: II Pensiero Scientifico 1966.
Heckmann, U.: Zur Wirkung des Norhydroxyprogesteroncapronat auf das Adeno carcinoma corporis uteri in der Gewebekultur. Dtsch. med. Wschr. 90,2328 (1965).
Hengstmann, H., u. D. Klien : Der Einfluß der weiblichen Sexualhormone auf die Faktoren des Prothrombinkomplexes und den Gerinnungsvorgang. Dtsch. Arch, klin. Med. 205,561 (1959).
Herrmann, U.: Zur gestagenen Wirkung von 6-Chlor-Aeetoxy-progesteron. Gynaecologia (Basel) 155,87 (1962).
Hertz, R.: Some unresolved problems connected with the use of oral contraceptive agent. Proceed. The Ford Foundation Int. Conf. on the physiology of human reproduction, Venice, p. 38 (1966).
Hillemanns, H. G., J. E. Ayre u. J. M. Le Guerrier: Die Einwirkung von Steroiden auf Krebsvorstadien an der Cervix. Arzneimittel-Forsch. 14,784 (1964).
Hoagland, H.: Endocrine control of fertility. Mod. Med. (Minneap.) 15,306 (1960).
Hohlweg, W.: Über die Bedeutung der Regulation der peripheren Hormondrüsen im Hinblick auf eine praktische Hormontherapie. Dtsch. Gesundh.-Wes. 8,245 (1956).
Hohlweg, W., u. G. Reiffenstuhl: Langzeitbehandlung mit Hormonen in der Gynäkologie. Wien. klin. Wschr. 77,878 (1965).
Hohlweg, W., u. G. Reiffenstuhl : LH-Secretion before, during and after treatment with ovulation inhibitors. Acta endocr. (Kbh.) 100,203 (1965).
Hohlweg, W., G. Reiffenstuhl, u. J. Schmor: Auslösung der Ovulation durch Gonadotropine, Hemmung der Ovulation durch Gestagene. Fortsehr. Geburtsh. Gynäk. 21,14 (1965).
Hollander, C. S., A. Garcia, S. H. Sturgis, and H. A. Selenkow: Effect of norethynodrel on thyroid. Mod. Med. (Minneap.) 31,82 (1963).
Hollander, C. S., A. Garcia, S. H. Sturgis, and H. A. Selenkow: Effect of an ovulatory suppressant on the serum protein-bound iodine and the red-cell uptake of radioactive tri-iodothyronine. New Engl. J. Med. 269,501 (1963).
Holmes, R. L., and A. M. Mandl: Oral contraceptives, an assessment of their mode of action. Lancet 19621,1174.
Holmstrom, E. G.: The long-term use of ovulen for contraception. Metabolism 14,444 (1965).
Hood, W. E., and W. L. Bond: Enovid therapy for premenstrual tension. Obstet, and Gynee. 14,239 (1959).
Hotjgie, C., R. N.Rutherford, A. L. Banks, and W. A. Coburn: Effect of a progestin - estrogen oral contraceptive on blood clotting factors. Metabolism 14,411 (1965).
Huggins, O.: Hormonabhängige Geschwülste - klinisch und experimentell. Klin. Wsehr. 36,1102 (1958).
Hutcherson, W. P., H. A. Schwartz, and W. Weathers: Long-term study of oral contraception with norethindrone 2 mg and mestranol 0,1 mg. Pertil. and Steril. 17,59 (1966).
I.P.P.F.: Medical handbook, 2nd ed. Paul & Mathew Ltd. 1965.
Ijzerman, G. L., M. N. G. Dukes u. H. Kopera: Klinische Ergebnisse der Fertilitätskontrolle nach cyclischer Anwendung von Lynestrenol in Kombination mit einem Oestrogen. Arzneimittel-Forsch. 13,507 (1963).
Jackson, M. C. N.: Methods of contraception. Practitioner 185,152 (1960).
Jackson, M. C. N.: Oral contraception in practice. J. Reprod. Fertil. 6,153 (1963).
Jackson, M. C. N., and R. Linn: Optimum dosage for estrogen-progestogen balance to inhibit ovulation. Int. J. Fertil. 9,75 (1964).
Jacobson, B. D.: Hazards of norethindrone therapy during pregnancy. Amer. J. Obstet. Gynec. 84,962 (1962).
Jacobziner, H., and H. W. Raybin: Accidental chemical poisonings. N.Y. St. J. Med. 63,2846 (1963).
Johannisson, E., K. G. Tillinger, and E. Diczfalusy: Effect of oral contraceptives on the ovarian reaction to human gonadotrophins in amenorrhoeic women. Fertil. and Steril. 16,292 (1965).
Junkmann, K.: Experimentelle Gesichtspunkte bei der Prüfung synthetischer Gesta gene. Dtsch. med. Wsehr. 88,629 (1963).
Junkmann, K. Die tierexperimentelle Prüfung antikonzeptioneller Steroide. Internist (Berl.) 5,238 (1964).
Käser, O.: Systemic effects of oral contraceptives. Proceed. The Ford Foundation Int. Conf. on the physiology of human reproduction, Venice, p. 44 (1966).
Kaiser, R.: Die Wirkung von Gestagenen beim Corpus-Carcinom. Arch. Gynäk. 193,195 (1958).
Kaiser, R. Der eytologische Effekt verschiedener gestagener Substanzen. 6. Symposion deutsche Ges. Endokrin., Kiel 1959,S. 64. Berlin-Göttingen-Heidelberg: Springer 1960.
Kaiser, R. The inhibition of ovulation with oral progestative substances. Int. J. Fertil. 9,87 (1964).
Kaiser, R. Hormonale Ovulationshemmung. Beiträge zur Fertilität und Sterilität, S. 87. Stuttgart: Ferdinand Enke 1964.
Kaiser, R. Vorverlegung, Verzögerung und Hemmung der Ovulation. Verh. 35. Tagg Dtsch. Ges. Gyn. München 1964. Arch. Gynäk. (im Druck).
Kaiser, R., u. U. Mohr: Zur Frage der Wirkung von Äthinylnortestosteronazetat auf das Wachstum bestimmter Sarkome. Z. Krebsforsch. 64,122 (1961).
Kanematsu, S. H., and Ch. H. Sawyer: Blockade of Ovulation in Rabbits on hypo thalamic implants of norethindrone. Endocrinology 76,686 (1965).
Kaufmann, C.: Progesteron, sein Schicksal im Organismus und seine Anwendung in der Therapie. Klin. Wsehr. 33,345 (1955).
Kelley, R. M., and W. H. Baker: Progestational agents in the treatment of carcinoma of the endometrium. New Engl. J. Med. 264,216 (1961).
Kennedy, B. J.: A Progestogen for treatment of advanced endometrial cancer. J. Amer. med. Ass. 184,758 (1963).
Kepp, R.: Orale Antikonzeption mit Hormonpräparaten. Landarzt 38,206 (1962).
Kincl, F. A. : Notiz über den Mechanismus der Anti-Ovulation mit 6-Chloro-J-6–17a- Aeetoxyprogesteron in Kaninchen. Endokrinologie 44,67 (1963).
Kirchhoff, H. : Sind männliche Hormonpräparate schon heute für die gynäkologische Praxis zu empfehlen ? (Einfluß des Erugon und Testoviron auf das weibliehe Genitale der Maus und des Kaninchens). Geburts. u. Frauenheilk. 2,572 (1940).
Kirchhoff, H. Können bei vorübergehend bettlägerigen Patientinnen weiter verordnete Kontra zeptiva eine Hyperkoagulabilität des Blutes bedingen ? Dtsch. med. Wschr. 91,187 (1966).
Kirchhoff, H. Hormonal treatment with oral contraceptives. Proceed. Fifth conference of I.P.P.F. Europe and Near East Region 1966.
Kirchhoff, H., u. J. Haller: Konzeptionsverhütung durch oral wirksame Gestagene, ein aktuelles Problem. Dtsch. med. Wschr. 84,49 (1959).
Kirchhoff, H., u. J.Haller, Ist die orale Empfängnisverhütung mit Gestagenen unschädlich ? Med. Klin. 56,290 (1961).
Kirchhoff, H., u. J.Haller, Klinische Erfahrungen mit einer ovulationsunterdrückenden Östrogen-Gestagen- Kombination (Anovlar). Med. Klin. 59,681 (1964).
Kirchhoff, H., u. J.Haller, Hormonale Ovulationshemmung, Referat Therapiekongreß Karlsruhe. Therapie woche 14,33 (1964).
Kirchhoff, H., u. J.Haller, Zur Verordnung von Ovulationshemmern. Niedersächs. Ärzteblatt 37,315 (1964).
Kirchhoff, H., and H. Poliwoda: Observations of the blood coagulation mechanism in patients treated with an oral fertility controlling agent (Anovlar-Schering). Proc. 7th Int. Planned Parenthood Fed., Singapore 1963. Excerpta med. (Amst.), Int. Congr. Ser. 72,341 (1964).
Kistner, R. W. : Histological effects of progestins on hyperplasia and carcinoma in situ of the endometrium. Cancer (Philad.) 12,1106 (1959).
Kloss, W.: Erfahrungen mit einem niedrig dosierten Gestagen-Östrogen-Gemiseh zur Ovulationshemmung. Med. Klin. 60,1029 (1965).
Knowles, E.: Oral contraceptive trial in the Fiji islands. Practitioner 196,551 (1966).
Kobayashi, T., Y. Yeda, S. Matsxjmoto, N. Ishizuka, and Taktjro Kobayashi: Oral contraception. Proc. 7th Conf. Int. Planned Parenthood Fed., Singapore 1963. Excerpta med. (Amst.), Int. Congr. Ser. 72,345 (1964).
Köker, H., u. H. Habermann: Erfahrungen mit dem niedrig dosierten Gestagen-Östrogen-Gemisch Etaiontin als Antikonzeptivum in der geburtshilflich-gynäkologischen Fachpraxis. Z. ärztl. Fortbild. 54,8 (1965).
Köpera, H., M. Dtjkes, and G. Ijzermann: Critical evaluation of clinical data on Lyndiol. Int. J. Fertil. 9,69 (1964).
Köpera, H., u. G. L. Ijzerman : Über Erfahrungen mit einer neuen ovulationshemmenden Kombination von Lynestrenol raid Mestranol. Ther. d. Gegenw. 103,657 (1964).
Krüskemper, H. L. : Structure-activity-relations of neutral steroids concerning their influence on liver function as measured by multiple parameters including blood coagulation factors. In: C. Cassano (ed.), Research on steroids, vol. II, p. 489. Rom: Il Pensiero Scientifico 1966.
Kühne, D. : Klinische Erfahrungen mit Ovosiston zur Ovulationshemmunsr. Dtsch. Gesundh.-Wes. 8,377 (1966).
Kümmel, J. : Beeinflussimg der Akne vulgaris durch Ovulationshemmer. Med. Welt 1966,138. Ref. Geburtsh. u. Frauenheilk. 9,1325 (1966).
Kuppermann, H. S. : Gonadotropic-inhibiting and uterotropic effects of Enovid. Proc. Symp. 19-Nor Progestational Steroids, Chicago, Searle Res. Lab., p. 32 (1957).
Kuppermann, H. S. Use of new progestational hormones. Fed. Proc. 18,1071 (1959).
Kuppermann, H. S., and J. A. Epstein : Gonadotropic-inhibiting and uterotropic effects of Enovid. Proc. 19-Nor Progestational Steroids, Chicago, Searle Res. Lab., p. 32 (1957).
Langecker, H. : Abspaltung von Acetvlen und Bildung von 17-Ketosteroiden aus 17a-Äthinyl-Nortestosteron und 17a-Athinyl-3,17ß-Östradiol durch Einwirkung von Alkali. Naturwissenschaften 46,601 (1959).
Larsson-Cohn, U.: Oral contraception and liver-function tests. Brit. med. J. 19651,No 5447,1414.
Larsson-Cohn, F., and U. Stenram : Jaundice during treatment with oral contraceptive agents. J. Amer. med. Ass. 193,422 (1965).
Laitritzen, C.: Effects of lynestrenol-methoxyethinyl-estradiol and of norethisterone acetate ethinylestradiol on the ovarian cycline function and on the endogenous hormone secretion. In: C. Cassano (ed.), Research on steroids, vol. II, p. 421. Rom: Il Penciero Scientifico 1966.
Latjweryns, J., and J. Ferin: Effects on the ovary of prolonged administration of Lynestrenol: A histological study. Int. J. Fertil. 9,35 (1964).
Layne, D. S., and C. J. Meyer: Effects of 19-Norsteroids on plasma-protein binding of hormones. Metabolism 14,429 (1965).
Layne, D. S., T. Golab, K. Arai, and G. Pincus: The metabolic fate of orally administered 3H-Norethynodrel and 3H-Norethindrone in humans. Biochem. Pharmacol. 12,905 (1963).
Layne, D. S., C. J.Mayer, P. S. Vaishwanar, and G. Pincus : The secretion and metabolism of Cortisol and aldosterone in normal and steroid-reated women. J. clin. Endocr. 22,107 (1962).
Lewis, J. M.: Clinical experience with norethynodrel and norethisterone as oral con traceptives. Proe. 7th Conf. Int. Planned Parenthood Fed., Singapore 1963. Exeerpta med. (Amst.), Int. Congr. Ser. 72,379 (1963).
Linthorst, G.: Hepatic impairment during the intake of contraceptive pills: Clinical trial with postmenopausal women. Brit. med. J. 1964II, No 5406,426.
Livingston, N. B.: Medroxyprogesterone acetate and estrogen to inhibit fertility. Int. J. Fertil. 8,699 (1963).
Loraine, J.: The effect of anti-ovulatory compounds on hormone excretion. Int. J. Fertil. 9,155 (1964).
Loraine, J. A., E. T.Bell, R. A.Harkness, E. Mears, and M. Jackson: Hormone excretion patterns during and after the long-term administration of oral contraceptives. Acta endocr. (Kbh.) 50,15 (1965).
A. L. Herbst, and M. Krishnamtjrti: The effect of long-term therapy with oral contraceptives on gonadotropin and steroid excretion. Proceed. The Ford Foundation Int. Conf. on the physiology of human reproduction, Venice, p. 48 (1966).
A. L. Herbst, and J. B. Brown: A method for the quantitative determination of gonadotrophins in the urine of non-pregnant human subjects. J. Endocr. 18,77 (1959).
Lxjdwig, H.: Gerinnungsphysiologische Untersuchungen im Zyklus der geschlechts reif en Frau und unter kontrazeptiver Medikation (Anovlar). Beiträge zur Fertilität und Sterilität, S. 116. Stuttgart: Ferdinand Enke 1964.
A. L.Herbst, Hämatologische und hämostaseologische Befunde bei der Ovulationshemmung durch Östrogen-Gestagen-Kombinationen. Fortsehr. Geburtsh. Gynäk. 21,198 (1965).
Lunenteld, B.: The ovarian response to exogenous human gonadotropins alone and during simultaneous administration of progestogens. Int. J. Fertil. 9,167 (1964).
Mass, J. M.: Withdrawal and breakthrough bleeding patterns attendant upon the use of certain aeetoxy progesterones. West. J. Surg. 71,224 (1963).
Macnaughton, M. C., and A. D. T. Go van: Ovarian effects of a new Oestrogen-Gestagen compound. In: C. Cassano (ed.), Research on steroids, vol.11,p. 431. Rom: II Pensiero Scientifieo 1966.
Mall, M., M. Arnold, St. Cloeren, E. More, R. H. H.Richter, Fr. Roth, H. Stamm u. H. Wyss : Vorläufige Resultate vergleichender Versuche mit oralen Kontrazeptiva, 1. Teil. Verh. Jahresversamml. der Schweiz. Gesellschaft f. Gynäkologie, Juni 1966,Lugano.
Mall-Haeeeli, M., K. S.Ludwig, M. Keller u. St. Cloeren: Beitrag zum Wirkungs mechanismus der oralen Ovulationshemmer beim Menschen. Gynaeeologia (Basel) 160,269 (1965).
Mammen, E. F., N. Aoki, A. C.Oliveira, M. I. Barnhart, and W. H. Seegers: Provest and blood coagulation tests. Int. J. Fertil. 8,653 (1963).
Manautou, J. M., M. Maqueo, R. A. Gilbert, and J. W. Goldzieher: Human endometrial activity of several new derivatives of 17-aeetoxyprogesterone. Fertil. and Steril. 13,169 (1962).
Maneschc, M., E. Cittadini, and P. Quartararo : The influence of estro-progestational treatments on the thyroid function. Exeerpta med. (Amst.), Int. Congr. Ser. 111,350 (1966).
Maqueo, M., C. Becerra, H. Munguia, and J. W. Goldzieher: Endometrial histology and vaginal cytology during oral contraception with sequential estrogen and progestin. Amer. J. Obstet. Gynee. 90,395 (1964).
Maqueo, M., E. Perez-Vega, J. W.Goldzieher, J. Martinez-Manautou, and H. Rudel: Comparison of the endometrial activity of 3 synthetic progestins used in fertility control. Amer. J. Obstet. Gynec. 85,427 (1963).
Margulies, R. R., J. L.Ambrus, I. B. Mink, and J. C. Stryker: Progestational agents and blood coagulation. Amer. J. Obstet. Gynec. 93,161 (1965).
Martinez-Manautou, J., V. Cortez, J. Giner, R. Aznar, J. Casasola, and H. W. Rudel: Low doses of progestogen as an approach to fertility control. Fertil. and Steril. 17,49 (1966).
Martini, L., and F. Fraschini : A new approach to the study of the mechanism of action of antiovulatory steroids. In: C. Cassano (ed.), Research on steroids, vol. II, p. 371. Rom: II Pensiero Scientifieo 1966.
Massenbach, W. v. : Über die unzweckmäßige Anwendung von Corpus-luteum-Hornion. Dtsch. med. Wschr. 07,513 (1941).
Matsumoto, S., T. Ito u. S. Inoije: Untersuchungen der ovulationshemmenden Wir kung von 19-Norsteroiden an laparotomierten Patientinnen. Geburtsh. u. Frauenheilk. 20,250 (1960).
Matsumoto, S. M., I. Sato, T. Ito, and A. Matsuoka: Electroencephalographic changes during long term treatment with oral contraceptives. Int. J. Fertil. 11,195 (1966).
Mattern, L.: Verlauf der Lungentuberkulose unter gleichzeitiger Behandlung mit Ovulationshemmern. Persönl. Mitt., November 1964.
Mazza, U., A. Cravario, L. Fiorina e V. Prato : Rapporti tra porfiria e gravidanza. Minerva med. 55,3967 (1964).
McGinty, D. A., and C. Djerassi: Some chemical and biological properties of 19-nor- 17a-ethynyltestosterone. Ann. N.Y. Acad. Sei. 71,500 (1958).
McGovern, J. J., J. P.Bunker, R. Goldstein, and J. W. Estes : Effect of con jugated estrogens on the coagulation mechanism. J. Amer. med. Ass. 175,1011 (1961).
McGowan, L.: Venous thrombophlebitis associated with the use of norethynodrel. Amer. J. Obstet. Gynec. 86,923 (1963).
McIntyre, N., M. J. Phillips, and J. C. Voigt: Two cases of thromboembolic disease associated with oral contraceptives. Brit. med. J. 1962 II, 1029.
McWilliam, R. S., A. J. McDonald, and I. Lindsay: Thrombophlebitic following the use of norethynodrel (Enovid). Canad. med. Ass. J. 88,1032 (1963).
Mears, E.: Trial of oral contraceptives. Lancet 1960 I, 491.
Mears, E. Clinical trials of oral contraceptives. Brit. med. J. 1961 II, 1179.
Mears, E. Oral contraceptives. Results of large scale clinical trials. Proc. 7th Conf. Int. Planned Parenthood Fed., Singapore 1963. Excerpta med. (Amst.), Int. Congr. Ser. 72,347 (1963).
Mears, E. Ovulation inhibitors. Family Planning 12,61 (1963).
Mears, E. A new type of oral contraceptives. Brit. med. J. 1963 I, 1318.
Mears, E. New oral contraceptives. Correspondence. Brit. med. J. 1963 II, 558.
Mears, E. Ovulation inhibitors: Large-scale clinical trials. Int. J. Fertil. 9,1 (1964).
Mears, E. Handbook on oral contraception (edited for the oral advisory group of the medical committee of the I.P.P.F., p. 965. London: J. &. A. Churchill Ltd. 1965.
Mears, E. Comparison of combined and sequential oral contraceptives. Excerpta med. (Amst.), Int. Congr. Ser. III, 196 (1966).
Mears, E., and E. C. G. Grant: “Anovlar” as an oral contraceptive. Brit. med. J. 1962II, 75.
Mehring, W.: Einfluß der Ovulationshemmer auf Vaginalbild und Portioepithel. Med. Klin. 60,2016 (1965).
Trials with Enovid: Proc. 7th Conf. Int. Planned Parenthood Fed., Singapore 1963. Excerpta med. (Amst.), Int. Congr. Ser. 72,355 (1963).
Metcalf, M. G., and D. W. Beaven: Plasma-eorticosteroid levels in women receiving oral contraceptive tablets. Lancet 1963 II, No 7317,1095.
Mey, R.: Zur Frage einer fetalen Maskulinisierung durch Progesteronbehandlung während der Gravidität. Beiträge zur Fertilität und Sterilität, S. 113. Stuttgart: Ferdinand Enke 1964.
Miller, Sh. P., St. L. Lee, and N. Ritz: Progestin-estrogen (SC 11800) therapy and the hemostatic mechanism - a controlled study. Metabolism 14,398 (1965).
Mellman, N., and C. G. Hartman: Oral control of conception. Fertil. and Steril. 7,110 (1956).
Moghessi, K. S., A. Rosenthal, and N. Moss: Provera-ethinyl estradiol for control of conception. Int. J. Fertil. 8,703 (1963).
Morris, J. A.: Physiologic control of conception with norethynodrel. Amer. J. Obstet. Genyc. 82,428 (1961).
Moyer, D. L., E. T.Tyler, H. J. Olson, and L. Zeldis: Vaginal exfoliative cytology in patients receiving progestogens. In: G. L.Wied, Proc. of the First Int. Congr. of Exfoliative Cytology, p. 236. Wien 31. 6. 61. Philadelphia: Lippincott 1962.
Mueller, M. N., and A. Kappas: Estrogen pharmacology. I. The influence of estradiol and estriol on hepatic disposal of sulfobromophthalein (BSP) in man. J. clin. Invest. 43,1905 (1964).
Müller, P. H.: Rezidivierende Lungenembolien mit sekundärer Thrombose der Pulmonalarterien bei Einnahme eines oralen Ovulationshemmers. Schweiz, med. Wschr. 95,1367 (1965).
Nelson, W. O.: Status of research on the physiologic control of fertility. Fertil. and Steril. 12,109 (1961).
Neyin, N. C., P. C. Elmes, and J. A. Weaver: Three cases of intravascular thrombosis occurring in patients receiving oral contraceptives. Brit. med. J. 19651,1586.
Ober, K. G.: Experimentelle Grundlagen der Progesteronbehandlung. 6. Sympos. dtsch. Ges. Endokrin., Kiel 1959,S. 76. Berlin-Göttingen-Heidelberg: Springer 1960.
Østergaard, E.: Inhibition of ovulation observed at laparotomy in patients treated with 6-dehydro-6-methyl-17a-acetoxyprogesterone (DMAP). Int. J. Fertil. 9,25(1964)
Østergaard, E., and J. Starup : Laparotomy observations during oral contraception. Proceed. Fifth Conf. I.P.P.F. Europe and Near East Region, Copenhagen (1966).
Østergaard, E. J.Arends, C. Hamburger, and S. G. Johnson: Postponement of menses, suppression of urinary gonadotrophs, 17-Kgs and 17-KS in normal women treated with a megastrol-acetate/mestranol combination (Delpregnin) from day 20 of the cycle. Acta endocr. (Kbh.), Suppl. 100,99 (1965).
Oldershausen, H. F. v., M. Eggstein, U. Dold u. K. Knörr: Ikterus bei intra hepatischer Cholestase nach Gaben von antikonzeptionellen Steroiden. Dtsch. med. Wsehr. 90,1290 (1965).
Olson, H. J.: Fertility promoting and inhibiting effects of new steroid hormonal sub stances. J. Amer. med. Ass. 169,1843 (1959).
Overbeek, G., and J. de Visser: Difficulties in determining the site of action of ovulation inhibitors. Int. J. Fertil. 9,177 (1964).
Palitz, L. L.: Abstract of a preliminary report on norethynodrel (Enovid) in the control of acne in the female. Arch. Derm. 86,237 (1962).
Palmer, R.: Celioscopic study of women treated with cyclic norethisterone for endo metriosis. Int. J. Fertil. 9,121 (1964).
Palva, I. P., and O. O. Mustala: Oral contraceptives and liver damage. Brit. med. J. 1964 I, 688.
Parkes, A. S.: Review of work with I.C.I. 33828: A nonsteroidal pituitary inhibitor. Proc. 7th Conf. Int. Planned Parenthood Fed., Singapore 1963. Exeerpta med. (Amst.), Int. Congr. Ser. 72,493 (1963).
Paulsen, C. A., R. B.Leach, J. Lanman, N. Goldston, W. O. Maddock, and C. G. Heller: Inherent estrogenieity of noethindrone and norethynodrel: Comparison with other synthetic progestins and progesterone. Endocrinology 70,1033 (1962).
Pearson, O. H., and C. P. Rhoads: Hormones and cancer. Practitioner 182,687 (1959).
Peeters, F., R. Oeyen, and M. Van Roy: Ovarian inhibition with progestogens: A study of the recuperation stage. Int. J. Fertil. 9,111 (1964).
Peeters, F., M. van Roy u. H. Oeyen: Ovulationsunterdrückung durch Progestagene. Geburtsh. u. Frauenheilk. 20,1306 (1960).
Peeters, F., M. van Roy u. H. Oeyen: Klinische Erfahrungen über die Ovulationshemmung durch Gestagene. Med. Klin. 56,1679 (1961).
R. Oeyen, R. Snauwaert u. A. van Tilborg: Medizinische Indikationen zur Hemmung der Ovulation. Internist (Berl.) 5,246 (1964).
Pepper, H., and St. Lindsay: Levels of platelets and eosinophilic leukocytes during the normal menstrual cycle and the administration of norethynodrel (Enovid). Int. J. Fertil. 8,467 (1963).
Perlroth, M. G., H. S. Marver, and D. P. Tschudy: Oral contraceptive agents and the management of acute intermittent porphyria. J. Amer. med. Ass. 194,1037(1965)
Peterson, D. L., R. A. Edgren, and R. C. Jones: Steroid-induced block of ovarian compensatory hypertrophy in hemicastrated female rats. J. Endocr. 29,255 (1964).
Peterson, W. F., M. W. Steel, and R. V. Coyne: Analysis of the effect of ovulatory suppressants on glucose tolerance. Amer. J. Obstet. Gynec. 95,484 (1966).
Phillips, L., R. N. Turksoy, and A. L. Southam: Influence of ovarian function on the fibrinolytic enzyme system. Amer. J. Obstet. Gynec. 82,1216 (1961).
Pilgeram, L. O.: Blood coagulability and oral contraception. Brit. med. J. 1964II, No 5387,883.
Pilgeram, L. O., and L. R. Pickart: Depression of plasma albumin by steroid therapy. Proc. Soc. exp. Biol. (N.Y.) 112,758 (1963).
Pincus, G.: Some effects of progesterone and related compounds upon reproduction and early development in mammals. Acta endocr. (Kbh.), Suppl. 28,18 (1956).
Pincus, G. Long term administration of Enovid to human subjects. Proc. of a Sympos. on 19-Nor Progestational Steroids, Chicago, Searle Res. Lab. 1957,p. 105.
Pincus, G.: The hormonal control of ovulation and early development. Postgrad. Med. 24,654 (1958).
Pincus, G.: Fertility control with oral medication. Stud. Fertil. 10,3 (1959).
Pincus, G. Progestational agents and the control of fertility. In: R. S.Harris, G. F.Marrian, K. Y.Thimann, Yitam. and Horm. 17,307 (1959).
Pincus, G. Fertility control by endocrine agents. Acta endocr. (Kbh.) 34,Suppl. 50,135 (1960).
Pincus, G. Clinical control of fertility. Advanc. Chemistry 44,177 (1964).
Pincus, G. The control of fertility. New York: Academic Press 1965.
Pincus, G. M. C.Chang, M. X.Zarrow, E. S. E. Hafez, and A. Merrill: Studies of the biological activity of eertein 19-norsteroids in female animals. Endocrinology 59,695 (1956).
Pincus, G., and C. R. Garcia: Studies on vaginal, cervical and uterine histology. Metabolism 14,344 (1965).
Pincus, G., and C. R.Garcia, M. Paniagua, and J. Shepard : Ethynodiol diacetate as a new, highly potent oral inhibitor of ovulation. Science 138,439 (1962).
Pincus, G., C. R.Garcia, J. Rock, M. Paniagua, A. Pendleton, F. Laraque, R. Nicolas, R. Borno, and Y. Pean: Effectiveness of an oral contraceptive. Science 130,81 (1959).
Pincus, G.,C. R.Garcia, J. Rock, M. C. Chang, and C.-R. Garcia: Effects of certain 19-nor steroids on reproductive processes and fertility. Fed. Proc. 18,1051 (1959).
Pincus, G.,C. R. Garcia, and C.-R. Garcia: Oral methods of fertility control: Field trials with norethy nodrel as an oral contraceptive. Proc. of the 6th Int. Conf. on Planned Parenthood, New Delhi 1959,p. 216.
E. Rice-Wray, M.Paniagua, and I. Rodriguez: Fertility control with oral medication. Amer. J. Obstet. Gynec. 75,1333 (1958).
Pochi, P. E., and J. S. Strauss: Lack of androgen effect on human sebaceous glands with low-dosage norethindrone. Amer. J. Obstet. Gynec. 93,1002 (1965).
Popper, H., u. F. Schaffner: Die Leber; Struktur und Funktion (Liver; structure and function). Deutsche Übersetzung und Bearbeitung von W. Eger und J. Haller. Stuttgart: Georg Thieme 1961.
Powell, L. Ch., M. M. Guest, and T. P. Bond : Coagulation and fibrinolytic studies in women receiving an anovulatory drug (medroxyprogesterone acetate with estradiol). Amer. J. Obstet. Gynec. 93,167 (1965).
Puccini, G.: Analysis of menstrual cycles in women treated with the sequential method. In: C. Cassano (ed.), Research on steroids, vol. II, p. 449. Rom: H Pensiero Scientific© 1966.
Puebla, R. A., A. Zarate, and R. B. Greenblatt: Ethynodiol diacetate: Clinical experience with a synthetic oral progestin. Fertil. and Steril. 16,805 (1965).
Pullen, D.: “Conovid-E” as an oral contraceptive. Brit. med. J. 1962II, 1016.
Pummer, M.: Erste Erfahrungen mit einem neuen oralen Antikonzeptivum. Landarzt 41,340 (1965).
Quick, A. J.: Oral contraception and coagulability. Brit. med. J. 19631,744.
Rauscher, H., u. A. Leeb : Beeinflussung der Ovulation. Fortsehr. Geburtsh. Gynäk. 21,165–170 (1965).
Reed, D. L., and W. W. Coon: Thromboembolism in patients receiving progestational drugs. New Engl. J. Med. 269,622 (1963).
Reifenstein, E. C., Th. E.Pratt, K. A. Hartzell, and W. B. Shafer: Artificial menstrual cycles induced in ovulating women by monthly injection of progestogen- estrogen. Fertil. and Steril. 16,652 (1965).
Rice-Wray, E.: Oral contraception in Latin America. Proc. 7th Conf. Int. Planned Parenthood Fed., Singapore 1963. Excerpta med. (Amst.), Int. Congr. Ser. 72,358 (1963).
Rice-Wray, E. Fertility after use of oral antiferitility agents and health of children born to these mothers. In: C. Cassano (ed.), Research on steroids, vol. II, p. 525. Rom. II Pensiero Scientifico 1966.
Rice-Wray, Q. E., A. Aranda-Rosell, M. Maqueo, and J. W. Goldzieher: Com parison of the long-term endometrial effects of synthetic progestins used in fertility control. Amer. J. Obstet. Gynec. 87,429 (1963).
Rice-Wray, E., S. Corren u. H. Gastelum: Erfahrungen mit dem oralen Kontra zeptivum Anovlar. Med. Klin. 61,11 (1966).
Rice-Wray, E., J. W. Goldzieher, and A. Aranda-Rosell: Oral progestions in fertility control: A comparative study. Fertil. and Steril. 14,402 (1963).
Rice-Wray, E., M. Schulz-Contreras, I. Guerrero, and A. Aranda-Rosell: Long-term ad ministration of norethindrone in fertility control. J. Amer. med. Ass. 180,355 (1962).
Rice-Wray, E., A. Carvantes, J. Gutierrez, A. Aranda-Rosell, and J. W. Goldzieher: The accep tability of oral progestins in fertility control. Metabolism 14,451 (1965).
Richter, H. H.: Neure Perspektiven für die Kontrolle der Fertilität. Ther. Umsch. 22,542 (1965).
Richter, R. H. H., M. Arnold, M. Mall, F. Roth, H. Stamm, H. Wyss, St. Cloeren, and E. More: Comparative trials with oral contraceptives. Proceed. Converence on the physiology of Human Reproduction sponsored by the Ford Foundation, Venice, p. 56 (1966).
H. Wyss, St. Cloeren, and E. More: Comparative trials with five oral contraceptives. In: C. Cassano (ed.), Research on steroids, vol. II, p. 441. Rom: II Pensiero Seientifico 1966.
Richter, R. H. H., and W. E. Schreiner: Die temporäre hormonale Sterilisierung der Frau und ihre Problematik. Ther. Umsch. 20,489 (1963).
Rimington, C., and F. de Matteis : Oral contraceptives and acute intermittent porphyria. Lancet 19651,270.
Rizk allah, T. H., and M. L. Taymor: Ovulation inhibition with a longacting injectable. II. The cycling effects of varying progestagen-estrogen combinations. Amer. J. Obstet. Gynec. 94,161 (1966).
Robinson, R. W., W. D. Cohen, and N. Higano : Clinical and serum lipid effects of a combination of norethynodrel plus ethynylestradiol 3-methyl ehter in postmenopausal women. Amer. J. med. Aci. 244,736 (1962).
Rock, J.: Inhibition of ovulation in the human. In: C. A.Villee, Control of ovulation. Proc. of the Conf. at Endicott House, Dedham, Mass., 1960,p. 222. New York: Pergamon Press 1961.
Rock, J. The time has come. New York: Hearst 1963.
Rock, J., C.-R. Garcia, J. McLeod, B. J. Pisani, and A. Southam: Fertility and infertility. Bull. N.Y. Acad. Med. 37,689 (1961).
Rock, J., C.-R. Garcia, and G. Pincus: In: G. E.Pincus, Recent progr. in hormone. Res. 13,323 (1957).
Rock, J., C.-R. Garcia, and G. Pincus, Use of some progestational 19-norsteroids in gynecology. Amer. J. Obstet. Gynec. 79,758 (1960).
Roland, M., M. J.Clyman, A. Decker, and W. B. Ober: Classification of endometrial response to synthetic progestogen estrogen compounds. Fertil. and Steril. 15,143 (1964).
Roland, M., M. J.Clyman, A. Decker, and W. B. Ober: Segmential Endometrial alterations during one cycle of treatment with synthetic progestagen-estrogen compounds. Fertil. and Steril. 17,3 (1966).
Rubin, A.: New progesteronie hormones in the control of fertility. Penn. med. J. 65,581 (1962).
Rutherford, R. N., A. L. Banks, and W. A. Coburn: Deladroxate for the prevention of ovulation. Fertil. and Steril. 15,648 (1964).
Ryan, G. M., D. A. Goss, and D. E. Reid : Pituitary gonadotropins during long-term Enovid-therapy. Amer. J. Obstet. Gynec. 94,515 (1966).
Sala, G., and E. Castegnaro : Effect of a progestinic-estrogenic combination on human adrenal function. In: C. Cassano (ed.), Research on steroids, vol. II, p. 405. Rom: II Pelsiero Scientifico 1966.
de Salcedo, I., M. D.Carrington, J. L. Silva, and F. M. Fonseca Ferreira: Some aspects of thyroid, adrenal and liver function during longterm administration of antifertility agents to healthy women. In: C. Cassano (ed.), Research on steroids, vol. II, p. 493. Rom: II Pensiero Scientifico 1966.
Samuels, A. J., F. Lepowsky, and E. Tyler: Assay of selected hematologic and coagulation factors in patients on provera. Int. J. Fertil. 8,665 (1963).
Sas, M., M. Gabor, L. Kovacs, I. Nemeth u. F. E. Szontagh: Untersuchungen über die Gerinnungsfaktoren während der Gestagen-Behandlung. Arch. Gynäk. 199,641 (1964).
Satterthwaite, A. P., and C. J. Gamble: Conception control with norethynodrel. J. Amer. med. Worn. Ass. 17,797 (1962).
Scarpellini, L.: Laboratory observations on the effects of three estrogen-progestin combinations on the human female genital tract. In: C. Cassano (ed.), Research on steroids, vol. II, p. 453. Rom: II Pensiero Scientifico 1966.
Schmelcher, R.: Die Verordnung sogenannter “Anti-Babypillen” in rechtlicher Sicht. Dtsch. med. Wsehr. 89,1522 (1964).
Schmidt-Elmendorff, H., u. H. Kopera: Der Einfluß von ovulationshemmenden Steroiden auf die FSH-LH- und Gesamtgonadotropin-Ausscheidung bei Frauen im gesehleehtsreifen Alter. Verhandl. 12. Sympos. Dtsch. Ges. f. Endokrinologie. Ber- lin-Heidelberg-New York: Springer 1966.
Schmidt-Elmendorff, H., u. H.Kopera, The effect of various antiovulatory compounds on the FSH, LH and “total gonadotrophin” excretion during the menstrual cycle. Proceedings Fifth World Congress on Fertility and Sterility Stockhom. Exeerpta med. (Amst.), Int. Congr. Ser. (im Druck.).
Schoceaert, J., and R. Mouunasse: Clinical observations with prolonged continuous administration of norethisterone acetate. Int. J. Fertil. 9,123 (1964).
Schöleb, H. F. L.: Anti-fertility effects with some retrosteroids in animal experiments. Proc. 7th Conf. Int. Planned Parenthood Fed., Singapore 1963. Exeerpta med. (Amst.), Int. Congr. Ser. 72,439 (1963).
Schreiner, W. E.: Die medikamentöse Geburtenregelung mit den modernen Ovu lationshemmern. Z. Präv.-Med. 7,507 (1962).
Schreiner, W. E. Die orale hormonale Antikonzeption. Zbl. Gynäk. 85,500 (1963).
Seegab-Jones, G.: Convention report (Am. College of Obstetr. and Gynevologists, Chicago). Prevention of conception. Mod. Med. (Minneap.) 30,9 (1962).
Segal, S. J., and W. O. Nelson: An orally active compound with antifertility effects in rats. Proc. Soc. exp. Biol. (N.Y.) 98,431 (1958).
Shafey, Sh., and P. Scheinberg : Neurological syndromes occurring in patients receiving synthetic steroids (oral contraceptives). Neurology (Minneap.) 16,205 (1966).
Shah, N. A., and J. C. Cobb : A preliminary report on the use of oral contraceptive pills synchronized with the phase of the moon. Proc. 7th Conf. Int. Planned Parenthood Fes., Singapore 1963. Exeerpta med. (A,st.), Int. Congr. Ser. 72,394 (1963).
Shearman, R. P.: Effects of the long-term use of ovulation inhibitors on the excretion of ovarian steroids. J. Reprod. Fertil. 5,457 (1963).
Siegel, P., u. G. Heinen: Die Reaktion des Endometriums auf die zyklische Behand lung mit Ovulationshemmern. Z. Geburtsh. u. Frauenheilk. 25,312 (1965).
Siegel, P., u. G.Heinen, Endometriumbefunde bei Ovulationshemmern. Arch. Gynäk. 202,248 (1965).
Sobrero, A. J.: Field trial of Provest as contraceptive. Int. J. Fertil. 8,721 (1963).
Soost, H. J.: Kolposkopische, zytologische und histologische Portiobefunde unter ovulationshemmender Medikation. Münch, med. Wschr. 107,489 (1965).
Sorcini, G.: Effect of norethynodrel-mestranol on plasmatic and urinary levels of testosterone. In: C. Cassano (ed.), Research on steroids, vol. II, p. 417. Rom: II Pensiero Scientifieo 1966.
Sotaniemi, E., K. E. Kretjs, and T. M. Scheinin: Oral contraceptives and liver damage, correspondence. Brit. med. J. 19651,No. 5440,393.
Southam, A. L.: A clinical evaluation of the 19-nor steroids. Med. Sei. 5,258 (1959).
Spellacy, W. N., and K. L. Carlson : Plasma insulin and blood glucose levels in patients taking oral contraceptives. Amer. J. Obstet. Gynecol. g5,474 (1966).
Staemmler, H.-J.: Über die Behandlung mit synthetischen Gestagenen. Dtsch. med. J. 13,293 (1962).
Staemmler, H.-J., u. C. Lauritzen: Pharmakologie und klinische Anwendung des Äthinyl-Nor- Testosteron. Zbl. Gynäk. 754 (1958).
Statzer, D. E., S. L. Cohn, and W. S. Floyd: An evaluation of norethindrone 2 mg with mestranol 0.11 mg in control of conception. Vertil. and Steril. 17,250 (1966).
Steiner, G. J., R. W. Kistner, and J. M. Craig: Histolofical effects of progestins on hyperplasia and carcinoma in situ of the endometrium-further observations. Metabolism 14,356 (1965).
Š těrba, R., A. Králova, J. Ulrych u. B. Valova: Die ersten klinischen Erfahrungen mit 16-Methylen-6-Dehydro-17α-Aeetoxyprogesteron (MDAP). Zbl. Gynäk. 87,540 (1965).
Stevens, Y. C., N. Yorys, P. K. Besch, and R. D. Barry: The effects of a new oral contraceptive on gonadotropin excretion. Metabolism 14,327 (1965).
Stoll, A., J. T.Andrews, R. Motteram, and J. Upfill: Oral contraceptives and liver damage. Brit. med. J. 1965 I, No 5436,723.
Stollreiter, L.: Bestehen Bedenken gegen eine hormonelle Antikonzeptionsbehand- lung bei Epilepsie ? Dtsch. med. Wschr. 89,1856 (1964).
Strade, H. A.: Lyndiol: Evaluation of safety and efficacy as an oral contraceptive. Curr. ther. Res. 8,265 (1966).
Strauss, J. B., u. P. E. Pochi: Wirkung der zyklischen Gestagen-Östrogen-Therapie auf Talgsekretion und Akne bei der Frau. J. Amer. med. Ass. 190,815 (1964).
Strauss, J. B., u. P. E.Pochi, Effect of Enovid on sebum production in females. Arch. Derm. 87,366 (1963).
Street, H. S.: Lond-term ovulation control with oral synthetic progestin. Clin. Med. 69,435 (1962).
Suchowsky, G. K., u. G. Baldratti: Zur Frage des Mechanismus der Ovulations- hemmung und vergleichende Untersuchungen der ehemischen Struktur und biologischen Wirkung einiger Steroide. Beiträge zur Fertilität und Sterilität, S. 92. Stuttgart: Ferdinand Enke 1964.
Stjmner, C. F., and P. N. Baer: Clinical observations of gingiva of patients on nor- ethynodrel therapy. J. Periodont. 38,344 (1962).
Swaab, L. I.: A field trial on Lyndiol and Enovid. Proc. 7th Conf. Int. Planned Parent hood Fed., Singapore 1963. Excerpta med. (Amst.), Int. Congr. Ser. 72,369 (1963).
Swaab, L.: A field trial with Lyndiol and Conovid. Int. J. Fertil. 9,107 (1964).
Swaab, L. I.: Oral contraceptives and liver damage. Brit. med. J. 1964,No 5411,755.
Swaab, L. I. Enige Resultaten bij de toepassing van orale ovulatieremmers (orale articonceptie). Ned. T. Geneesk. 108,1070 (1964).
Swaab, L. I. Blood pressure and oral contraception. Excerpta med. (Amst.), Int. Congr. Ser. III, 198 (1966).
Swartz, D. P., J. H.Walters, E. R. Plunkett, and R. A. H. Kinch: Clinical experience with a new oral contraceptive. Fertil. and Steril. 14,320 (1963).
Swyer, G. I. M.: Oral contraceptives. Practitioner 190,155 (1963).
Swyer, G. I. M. Small9scale clinical trials of progestogens for control of conception. Int. J. Fertil. 9,11 (1964).
Swyer, G. I. M. The safety of oestrogen/progestagen oral contraceptives. Excerpta med. (Amst.), Int. Congr. Ser. 111,10 (1966).
Swyer, G. I. M., and V. Little : Absence of hepatic impairment in long-term oral contraceptive users. Brit. med. J. 1965 H, 1412.
Szontagh, F. E., u. M. Sas : Zur Frage der ovulationshemmenden Dosis oraler Gestagene. Zbl. Gynäk. 410 (1964).
Tait, A. S.: Oral contraceptives. Med. J. Aust. 52,667 (1965).
Takano, K., H. Yamamura, M. Suzuki, and H. Nishimura: Teratogenic effect of Chlormadinon acetate in mice and rabbits. Proc. Soc. exp. Biol. (N.Y.) 121,445 (1966).
Taymor, M. L., St. Planck, and Cl. Yahia: Ovulation inhibition with a longacting parenteral progestogen-estrogen combination. Fertil. and Steril. 15,657 (1964).
Tenyi, M., S. Sebök, F. E. Szontagh u. M. Földi: Zur Frage der Wirkung oraler Progestagene auf den Kohlenhydratstoffwechsel. Endokrinologie (1966) (im Druck).
Thiery, M.: Should genital candidosis be considered a side effect or oral contraception ? Proceed. Fifth Conf. I.P.P.F. Europe and Near East Region, Copenhagen (1966).
Tietze, K., u. W. Jaensch-Zander: Zur Frage einer kanzerogenen Wirkung der Ovulationshemmer. Dtsch. Ärztebl. 10,635 (1966).
Toaee, R., and R. Jewelewicz: Inhibition of lactogenesis by combined oral progesto gens and oestrogens. Lancet 1963 II, 322.
Toivakka, E.: Oral contraception in epileptics. Drug Res. (im Druck).
Topete, M. M., and E. Rice-Wray: The effect of estrogens, progestins and combina tions of estrogens and progestins on the human endometrium. In: C. Cassano (ed.), Research on steroids, vol. II, p. 463. Rom: II Pensiero Scientifico 1966.
Toth, F.: Über die klinische Bedeutung der synthetischen Progesteroide und ihre etwaige Rolle bei der Karzinogenese. Z. Geburtsh. Gynäk. 161,94 (1963).
Toth, F. The effect of synthetic progestogens on the ovaries. Int. J. Fertil. 9,151 (1964).
Toth, F. The inhibiting effect of a norsteroid on tumor formation and on the metabolism of tumor cells. Amer. J. Obstet. Gynee. 94,518 (1966).
Trampuz, V.: Limitations in use of contraceptives. In: C. Cassano (ed.) Research on steroids, vol. II, p. 439. Rom: II Pensiero Scientifico 1966.
Tscherne, E.: Zur Frage der Ovulationshemmung. Zbl. Gynäk. 84,1581 (1962).
Turksoy, R. N., L. Lang Phillips, and A. L. Southam: Influence of ovarian function on the fibrinolytic enzyme system. Amer. J. Obstet. Gynee. 82,1211 (1961).
Turpeinen, K.: Ovulation inhibition by Lyndiol: A clinical trial. Int. J. Fertil. 9,137 (1964).
Tyler, E. T.: The use of steroid substances as a clinical antifertility agents. Proc. of the 6th Int. Conf. on Planned Parenthood, NewDelhi 1959,p. 237.
Tyler, E. T. Norethinedrone in clinical antifertility studies. Acta endocr. (Kbh.) 35,Suppl. 51,933 (1960).
Tyler, E. T. Oral contraception. J. Amer. med. Ass. 175,225 (1961).
Tyler, E. T. Comparative statistics on a variety of oral contraceptive preparations. Proc. 7th Conf. Int. Planned Parenthood Fed., Singapore 1963. Excerpta med. (Amst.), Int. Congr. Ser. 72,373 (1963).
Tyler, E.: Oral contraception and venous thrombosis. J. Amer. med. Ass. 185,131 (1963).
Tyler, E. T.: Current status of oral contraception. J. Amer. med. Ass. 187,562 (1964).
Tyler, E. T. Oral contraceptives and liver damage. Brit. med. J. 1964II, No 5419,1264.
Tyler, E. T., and H. J. Olson: Clinical use of new progestational steroids in fetility. Ann. N.Y. Acad. Sei. 71,704 (1958).
Tyler, E. T., and H. J. Olson: Fertility promoting and inhibiting effects of new steroid hormonal substances. J. Amer. med. Ass. 169,1843 (1959).
Tyler, E. T., and H. J.Olson, L. Wolf, S. Finkelstein, J. Thayer, N. Kaplan, M. Leyin, and J. Weintraub : An oral contraceptive. A 4-year study of norethindrone. Obstet, and Gynec. 18,363 (1961).
Ufer, J.: Zur hormonalen Konzeptionsverhütung. Med. Ellin. 59,1089 (1964).
van de Kercebove, D. A.: An unusual endometrial response adter long-term admini stration of lynestrenol methoxyethinylestradiol. In: C. Cassano (ed.), Research on steroids, vol. II, p. 485. Rom: II Pensiero Scientifico 1966.
Vanek, R.: Ovarian inhibition with ethynodiol-diaeetate: Influence of steroidgenesis. Int. J. Fertil. 9,129 (1964).
Varga, A., and E. Henriksen: Clinical and histopathologic evaluation of the effect of 17-alpha-hydroxyprogesterone-17-n-caproate on endometrial carcinoma. Obstet, and Gynec. 18,658 (1961).
Varga, A., Effect of 17-alpha-Hydroxyprogesterone-17-n-caproate on various pelvic malignancies. Obstet, and. Gynec. 23,51 (1964).
Vasicka, A., and F. J. Richter: Effect of Enovid on the human ovary, endometrium and vaginal mears during the preovulatory phase. Surg. Forum 10,730 (1960).
Venning, G. R.: The influence of contraceptive practice upon maternal and child health. Metabolism 14. 457 (1965).
Venning, G. R. Reduction in the birthrate in a community associated with the administration of oral contraceptives. In: C. Cassano (ed.), Research on steroids, vol. II, p. 435. Rom: II Pensiero Scientifico 1966.
Verhagen, A., u. H. Theman: Elektronenmikroskopische Endometriumbefunde nach Behandlung mit ovulationshemmenden Stoffen. Arch. Gynäk. 202,253 (1965).
Vorys, N., J. C. Ullery, and V. Stephens: The effects of sex steroids on gonado- trophins. Amer. J. Obstet. Gynec. 93,641 (1965).
Wachtel, E.: Cytological patterns during administration of antifertility pills, with special reference to norethisterone acetate - ethinylestradiol, lynestrenol-mestranol and sequential therapy. In: C. Cassano (ed.), Research on steroids, vol. II, p. 459. Rom: II Pensiero Scientifico 1966.
Wade, Self L.: Pituitary cytology of rats receiving ethynodiol diacetate and mestranol for 2 years. Metabolism 14,311 (1965).
Wagner, H.: Spezielle Untersuchungen über die neueren Gestagene. Münch, med. Wschr. 105,1517 (1963).
Wallach, E. E., C.-R. Garcia, R. W. Kistner, and G. Pinctts: Adrenal function during long-term Enovid administration. Amer. J. Obstet. Gynec. 87,991 (1963).
Walser, H., R. Margtjlis, and J. Ladd: Effects of prolonged administration of progestins on the endometrium and the function of the pituitary, thyroid and adrenal glands. Int. J. Fertil. 9,189 (1964).
Wattnick, A. S., J. Gibson, M. Vinerga, and S. Tolksdorf: The comparative contraceptive activities of 10β-hydroperoxy-17α-ethynyl-4-estren-17β-ol-3-one (Sch 10015) and norethynodrel. J. Endocr. 33,241 (1965).
Watts, G. F., and A. W. Diddle: Oral use of 19-nor-17β-ethinyl-testosterone to control fertility. Amer. J. Obstet. Gynec. 83,1132 (1962).
Watts, G. F., and A. W.Diddle, W. H. Gardner, and P. J. Williamson: Pregnancy following withdrawal from oral contraceptive measures. Amer. J. Obstet. Gynec. 90,401 (1964).
Weber, L. M.: Hormon-Präparate im Dienste ethisch vertretbarer Geburtenregelung. Arzt und Christ 2,116 (1961).
Wetterberg, L.: Oral contraceptives and acute intermittent porphyria. Lancet 1964 II, 1178.
W.H.O.: Mechanism of action of sex hormones and analogous substances. Wld Hlth Org. teehn. Rep. Ser. 303,(1965).
W.H.O. Clinical aspects of oral gestogens. Wld Hlth Org. techn. Rep. Ser. 326,(1966).
Wied, G. L., and M. E. Davis: Provest and Provera: A comparative study. Int. J. Fertil. 8,601 (1963).
Wilkins, L.: Masculinization of the female fetus due to the use of certain synthetic oral progestins during pregnancy. Arch. Anat. micr. Morph, exp. 48,313 (1959).
Wilkins, L. Masculinization of female fetus due to use of orally given progestins. J. Amer. med. Ass. 172,1028 (1960).
Wilkins, L. H. W.Jones, G. H. Holman, and R. S. Stempel: Masculinization of the female fetus associated with administration of oral and intramuscular progestins during gestation: Nonadrenal female pseudohermaphrodism. J. clin. Endocr. 18,559 (1958).
Winter, I. C.: The incidence of thromboembolism in Enovid risers. Metabolism 14,422 (1965).
Zanartu, J.: Effect of synthetic oral gestagens on cervical mnscus and sperm penetra tion. Int. J. Fertil. 9,225 (1964).
Zanartu, J., and C. Navarro : Long-acting depo progestagens associated with oral estrogens in human fertility control. Excerpta med. (Amst.), Int. Congr. Ser. 111,351 (1966).
Zander, J.: Die Ausscheidung des Pregnandiolkomplexes nach Injektion von Prog esteron beim Menschen. Geburtsh. u. Frauenheilk. 14,402 (1954).
Zander, J. Die gestagen wirksamen Hormone im Organismus. Geburtsh. u. Frauenheilk. 17,876 (1957).
Zander, J. Neuere Erkenntnisse über die natürlichen Gestagene im menschlichen Organismus. 6. Sympos. dtsch. Ges. Endokr. Kiel 1959,S.U. Berlin-Göttingen-Heidelberg: Springer 1960.
Zander, J., u. H. A. Müller: Über die Methylandrostendiolbehandlung während einer Schwan gerschaft. Geburtsh. u. Frauenheilk. 13,216 (1953).
Editor information
Rights and permissions
Copyright information
© 1968 Springer-Verlag / Berlin · Heidelberg
About this chapter
Cite this chapter
Haller, J. (1968). Die antikonzeptionelle Therapie. In: Damrosch, L., et al. Die Gestagene. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 22 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-99941-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-99941-3_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-99942-0
Online ISBN: 978-3-642-99941-3
eBook Packages: Springer Book Archive